共 184 条
[1]
Leucht S(2013)Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis Lancet 382 951-962
[2]
Cipriani A(2005)Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 1209-1223
[3]
Spineli L(2018)Two-year effectiveness of risperidone and aripiprazole in the maintenance treatment of patients with recent-onset or chronic schizophrenia and related psychotic disorders: a retrospective multicenter study Int Clin Psychopharmacol 33 147-154
[4]
Mavridis D(2011)Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging Pharmacopsychiatry 44 236-248
[5]
Örey D(1999)Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia Am J Psychiatry 156 286-293
[6]
Richter F(2013)Pharmacogenetics of clinical response to risperidone Pharmacogenomics 14 177-194
[7]
Lieberman JA(2018)Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017 Pharmacopsychiatry 51 9-62
[8]
Stroup TS(2015)Clinical applications of CYP genotyping in psychiatry J Neural Transm (Vienna) 122 5-28
[9]
McEvoy JP(2010)The pharmacokinetics of paliperidone versus risperidone Psychosomatics 51 80-88
[10]
Swartz MS(2013)Pharmacogenetics of risperidone: a systematic review of the clinical effects of CYP2D6 polymorphisms Ann Pharmacother 47 350-360